Warning letter
Auro Pharmacies, Inc.: warning letter of Dec 13, 2016
FDA warning letter 499142 · Los Angeles District Office
Key facts
| Reference number | 499142 |
|---|---|
| Company | Auro Pharmacies, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Dec 13, 2016 |
| Posted date | Jan 31, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.167(a), 211.166(a), 201.115, 211, 211.192, 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.67(a), 211.113(b) |
| Inspection city | La Habra |
| Inspection ZIP | 90631 |
| Inspection start date | Sep 22, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: